...Daniel Christman, the US Chamber of Commerce senior vice president for international affairs, said in Bangkok yesterday...that the biggest concerns of US businessmen now is Thailand's decision to impose the compulsory licensing on certain drugs...The US Chamber of Commerce's survey of 234 business executives from across five continents, showed that Thailand's new economic policies and poor intellectual property safeguards could be jeopardising international investment. Christman wants to see the government have more direct talks with the private sector...[refers to Abbott, Sanofi-Aventis, Bristol-Myers Squibb, Efavirenz (patented by Merck)]